Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AVA-001 by Avalon GloboCare for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
AVA-001 is under clinical development by Avalon GloboCare and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute...
Data Insights
AVA-001 by Avalon GloboCare for Non-Hodgkin Lymphoma: Likelihood of Approval
AVA-001 is under clinical development by Avalon GloboCare and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase...